• |
Neurontin
Manufacturer: Pfizer
Neurontin (gabapentin) is indicated for the management of postherpetic neuralgia in adults.
Neurontin is also used to help relieve certain types of nerve pain, and may be prescribed for other nervous system disorders.
Neurontin was launched into the marketplace in February of 1994; from mid-1995 to at least 2001, the growth of off-label sales was tremendous.
Recent litigation and congressional inquiry have provided access to pharmaceutical industry documents that shed light on the marketing strategies used to promote drugs (1). One example is the case of gabapentin (Neurontin, Pfizer, Inc., New York, New York)
[April 22, 2005 - Press Release - Pfizer]
Pfizer Inc., the world's largest pharmaceutical company, on May 13, 2004 plead guilty and agreed to pay $430 million to resolve all criminal charges and civil liabilities related to the illegal and fraudulent marketing of its top selling epilepsy drug Neurontin by Warner-Lambert's Parke-Davis Division.
Drug giant accused of false claims
July 11 — The questions began with the confession of an insider at one of the nation’s largest pharmaceutical firms. He says his former company deliberately distorted information about one of its drugs, possibly putting lives at risk, and costing patients and taxpayers millions of dollars. “Dateline” went looking for some answers and has the results of a year-long investigation into what may be one of the biggest medical deceptions in history.